Use and clinical impact of conventional cytotoxic chemotherapy (CTx) subsequent to immunotherapy in metastatic melanoma

被引:1
|
作者
Malone, E. R. [1 ]
Maltese, M. [1 ]
Coady, L. [1 ]
Hammond, L. [1 ]
Silva, N. [1 ]
Gullo, G. [1 ]
Crown, J. [1 ]
机构
[1] St Vincents Univ Hosp, Med Oncol, Dublin, Ireland
关键词
D O I
10.1093/annonc/mdw379.45
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
1150P
引用
收藏
页数:1
相关论文
共 50 条
  • [1] Benefit from subsequent conventional cytotoxic chemotherapy (CTx) to immunotherapy (IT) in patients (pts) with gynaecological malignancies (GM)
    Ros Montana, F. J.
    Rodriguez Freixinos, V.
    Farinas Madrid, L.
    Amair Pinedo, F.
    Ruiz-Pace, F.
    Garralda, E.
    Dienstmann, R.
    Oaknin, A.
    ANNALS OF ONCOLOGY, 2018, 29 : 353 - 353
  • [2] Impact of previous immunotherapy on chemotherapy efficacy in metastatic melanoma
    Fang, M.
    Fang, M.
    ANNALS OF ONCOLOGY, 2022, 33 : S1613 - S1613
  • [3] SEQUENTIAL CHEMOTHERAPY AND IMMUNOTHERAPY FOR THE TREATMENT OF METASTATIC MELANOMA
    SCHUCHTER, LM
    WOHLGANGER, JA
    FISHMAN, EK
    MACDERMOTT, ML
    MCGUIRE, WP
    JOURNAL OF IMMUNOTHERAPY, 1992, 12 (04): : 272 - 276
  • [4] Outcomes From Cytotoxic Chemotherapy Following Progression on Immunotherapy in Metastatic Melanoma: An Institutional Case-Series
    Gaughan, Elizabeth M.
    Horton, Bethany J.
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [5] Clinical Trials in Metastatic Uveal Melanoma: Immunotherapy
    Orloff, Marlana
    OCULAR ONCOLOGY AND PATHOLOGY, 2021, 7 (03) : 168 - 176
  • [6] Is there still a role for cytotoxic chemotherapy after targeted therapy and immunotherapy in metastatic melanoma?A case report and literature review
    Aurélien Simon
    Hampig Raphael Kourie
    Joseph Kerger
    ChineseJournalofCancer, 2017, 36 (04) : 44 - 48
  • [7] Is there still a role for cytotoxic chemotherapy after targeted therapy and immunotherapy in metastatic melanoma? A case report and literature review
    Simon, Aurelien
    Kourie, Hampig Raphael
    Kerger, Joseph
    CHINESE JOURNAL OF CANCER, 2017, 36
  • [8] Intrathecal cytotoxic T-cell immunotherapy for metastatic leptomeningeal melanoma
    Clemons-Miller, AR
    Chatta, GS
    Hutchins, L
    Angtuaco, EJ
    Ravaggi, A
    Santin, AD
    Cannon, MJ
    CLINICAL CANCER RESEARCH, 2001, 7 (03) : 917S - 924S
  • [9] Impact of sarcopenia in patients with metastatic melanoma treated with immunotherapy
    Vitale, M. G.
    Basile, D.
    Bertoli, E.
    Giavarra, M.
    Pelizzari, G.
    Palmero, L.
    Zara, D.
    Targato, G.
    Pascoletti, G.
    Cinausero, M.
    Poletto, E.
    Iacono, D.
    Puglisi, F.
    Fasola, G.
    Minisini, A. M.
    ANNALS OF ONCOLOGY, 2019, 30 : 558 - 558
  • [10] Salvage chemotherapy in the treatment of metastatic melanoma after progression on immunotherapy.
    Shah, Payal
    Boland, Patrick
    Pavlick, Anna C.
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)